Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Pukrop, Tobias"'
Autor:
Harrer, Dennis Christoph, Lüke, Florian, Pukrop, Tobias, Ghibelli, Lina, Gerner, Christopher, Reichle, Albrecht, Heudobler, Daniel
Publikováno v:
Frontiers in Oncology; 2024, p01-16, 16p
Autor:
Harrer, Dennis Christoph, Buschauer, Sebastian, Sterz, Ulrich, Menhart, Karin, Wendl, Christina, Heudobler, Daniel, Grube, Matthias, Pukrop, Tobias, Herr, Wolfgang, Vogelhuber, Martin
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundMetastasized soft-tissue sarcomas still pose a significant therapeutic challenge given the limited efficacy of currently available multimodal treatment strategies. Recent progress in molecular characterization of sarcoma subtypes has enable
Autor:
Lüke, Florian, Harrer, Dennis Christoph, Pantziarka, Pan, Pukrop, Tobias, Ghibelli, Lina, Gerner, Christopher, Reichle, Albrecht, Heudobler, Daniel
Publikováno v:
Frontiers in Oncology; 6/24/2022, Vol. 12, p1-18, 18p
Autor:
Blazquez, Raquel, Proescholdt, Martin Andreas, Klauser, Marlene, Schebesch, Karl-Michael, Doenitz, Christian, Heudobler, Daniel, Stange, Lena, Riemenschneider, Markus J., Bumes, Elisabeth, Rosengarth, Katharina, Schicho, Andreas, Schmidt, Nils-Ole, Brawanski, Alexander, Pukrop, Tobias, Wendl, Christina
Publikováno v:
Frontiers in Oncology; 4/4/2022, Vol. 12, p1-9, 9p
Autor:
Heudobler, Daniel, Rechenmacher, Michael, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Thomas, Simone, Pukrop, Tobias, Hackl, Christina, Herr, Wolfgang, Ghibelli, Lina, Gerner, Christopher, Reichle, Albrecht
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 9 (2018)
Frontiers in Pharmacology, Vol 9 (2018)
Classic tumor therapy, consisting of cytotoxic agents and/or targeted therapy, has not overcome therapeutic limitations like poor risk genetic parameters, genetic heterogeneity at different metastatic sites or the problem of undruggable targets. Here
Autor:
Lüke, Florian, Harrer, Dennis C., Hahn, Joachim, Grube, Matthias, Pukrop, Tobias, Herr, Wolfgang, Reichle, Albrecht, Heudobler, Daniel
Publikováno v:
Frontiers in Pharmacology; 6/2/2021, Vol. 12, p1-5, 5p
Autor:
Johannesen, Siw, Huie, J. Russell, Budeus, Bettina, Peters, Sebastian, Wirth, Anna M., Iberl, Sabine, Kammermaier, Tina, Kobor, Ines, Wirkert, Eva, Küspert, Sabrina, Tahedl, Marlene, Grassinger, Jochen, Pukrop, Tobias, Schneider, Armin, Aigner, Ludwig, Schulte-Mattler, Wilhelm, Schuierer, Gerhard, Koch, Winfried, Bruun, Tim-Henrik, Ferguson, Adam R.
Publikováno v:
Frontiers in Neurology; 3/18/2021, Vol. 11, pN.PAG-N.PAG, 15p
Autor:
Bayerlová, Michaela, Menck, Kerstin, Klemm, Florian, Wolff, Alexander, Pukrop, Tobias, Binder, Claudia, Beißbarth, Tim, Bleckmann, Annalen
Publikováno v:
Frontiers in Oncology. 7
Breast cancer is a heterogeneous disease and has been classified into five molecular subtypes based on gene expression profiles. Signaling processes linked to different breast cancer molecular subtypes and different clinical outcomes are still poorly
Autor:
Heudobler, Daniel, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Pukrop, Tobias, Herr, Wolfgang, Gerner, Christopher, Pantziarka, Pan, Ghibelli, Lina, Reichle, Albrecht
Publikováno v:
Frontiers in Oncology; 12/20/2019, Vol. 9, p1-22, 22p
Autor:
Heudobler, Daniel, Schulz, Christian, Fischer, Jürgen R., Staib, Peter, Wehler, Thomas, Südhoff, Thomas, Schichtl, Thomas, Wilke, Jochen, Hahn, Joachim, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Pukrop, Tobias, Herr, Wolfgang, Held, Swantje, Beckers, Kristine, Bouche, Gauthier, Reichle, Albrecht
Publikováno v:
Frontiers in Pharmacology; 3/16/2021, Vol. 11, pN.PAG-N.PAG, 1p